Core Viewpoint - The investigation reveals that many products labeled as "yogurt" on e-commerce platforms are actually low-nutrition flavored drinks, failing to meet the national yogurt standards [1][2]. Group 1: Product Standards and Compliance - None of the seven products tested adhered to the GB 19302-2010 national standard for fermented milk, with four products having protein content below the GB/T 21732-2008 standard for dairy beverages [2]. - The cost of these products is approximately 0.3 to 0.4 yuan per bottle, with a factory price around 0.7 yuan per bottle, primarily sold in lower-tier cities and wholesale markets [2]. - Manufacturers often have multiple product labels ready to quickly rebrand and resume sales if a product is reported or removed [2]. Group 2: Regulatory Actions and Consequences - Following the report, six of the seven products were quickly removed from sale, with some companies changing product names to comply with regulations [7][10]. - The production company for "Dongzhi One Can Yogurt" was fined over 120,000 yuan for violating the Food Safety Law [10]. - The production company for "Aiyangniu Daily Yogurt" and "Anmuguo Le Duo Daily Yogurt" had its food production license revoked and was listed as a serious violator of trust [10][11]. Group 3: Misleading Marketing Practices - The prominent labeling of "yogurt" on products that do not meet yogurt standards is considered misleading and potentially deceptive to consumers [3]. - Experts indicate that the marketing practices of highlighting "yogurt" while using smaller text for "drink" or "beverage" are violations of food labeling regulations [2][3]. - The use of misleading terms can lead to accusations of false advertising if the nutritional claims do not match the actual product [3]. Group 4: Consumer Awareness and Education - Consumers are advised to differentiate between "yogurt," "fermented milk," and "yogurt drinks" by examining ingredient lists and nutritional content [13][14]. - The definition of yogurt requires a minimum of 80% raw milk content, while flavored drinks do not have specific requirements for milk content [13][14].

Core Viewpoint - The company "Northeast Brothers" has been fined 200,000 yuan for false advertising related to organic products and misrepresentation of greenhouse numbers, following complaints from local farmers about unfulfilled purchase commitments [1][2][3]. Group 1: Company Actions and Penalties - "Northeast Brothers" was penalized for selling products labeled as organic without proper certification and for exaggerating the number of greenhouses they operated, claiming 200 when only 6 were verified [3][6]. - The company generated a total revenue of 331,423.39 yuan during the period of the violations [3]. - The local market supervision bureau has mandated "Northeast Brothers" to rectify their business practices and ensure truthful advertising in future livestreams [6]. Group 2: Farmer Complaints and Responses - Local farmers reported that "Northeast Brothers" failed to honor their commitment to purchase all of their Lingzhi spore powder, leading to significant unsold inventory [4][5]. - Despite a public apology in September, the company has not followed through on its promises to support local farmers, with only 150 kilograms of spore powder purchased from two farmers [5]. - Farmers have expressed frustration over the lack of communication and resolution from both "Northeast Brothers" and local authorities regarding their grievances [4][5]. Group 3: Market Presence and Sales Performance - "Northeast Brothers" has over 700,000 followers on social media and has conducted numerous livestreams, with average sales ranging from 7,500 to 10,000 yuan per session in 2024 [6]. - In 2023, the company held 173 livestreams with average sales of 2,500 to 5,000 yuan, indicating a decline in performance compared to the previous year [6].

Core Viewpoint - The rise of "liquid masks" as a nasal spray product is linked to the recent outbreak of influenza, attracting consumers looking for alternatives to traditional masks, despite concerns about its efficacy and potential misleading claims [1][2]. Group 1: Product Description and Popularity - "Liquid masks" are marketed as a nasal spray that creates a "physical barrier" to block viruses, claiming a "99.9% blocking rate" and promoting a slogan of "everyone can take off their masks" [1]. - The product has gained popularity on e-commerce platforms, with some brands reportedly selling over 1 million bottles annually, appealing to consumers who find traditional masks uncomfortable or unattractive [1][2]. Group 2: Expert Opinions on Efficacy - Experts express skepticism about the claims made by "liquid masks," emphasizing that they do not replace traditional masks, which have established scientific backing for their effectiveness in reducing virus transmission [3][4]. - The traditional masks are noted for their clear technical standards and proven ability to reduce droplet transmission by over 70% when worn correctly [3]. Group 3: Regulatory and Safety Concerns - "Liquid masks" are classified as everyday consumer products rather than medical devices, lacking large-scale clinical validation for their advertised protective effects [2][4]. - Legal experts warn that the claims of "99.9% virus blockage" may constitute false advertising, urging consumers to be cautious and for e-commerce platforms to monitor misleading promotional content [2]. Group 4: Limitations and Risks - The protective effect of "liquid masks" is limited, as they primarily rely on a gel layer that may not effectively filter out viruses smaller than 0.1 microns, and potential side effects such as nasal dryness and irritation have not been thoroughly evaluated [5][6]. - Experts highlight that while the gel may adsorb some viruses, the overall effectiveness is compromised by the possibility of virus transmission through the mouth, indicating that the product should not be relied upon as a primary protective measure [6].

12月15日，北京同仁堂健康药业股份有限公司发布声明称，近日有媒体报道一款标注"安徽哈博药业有 限公司生产、北京同仁堂（四川）健康药业有限公司经销"的"99%高纯南极磷虾油"产品，相关成分涉 嫌虚假标注。 针对上述情况，公司立即责令四川健康药业停止经销该产品，并对涉事产品开展全流程核查与追溯。这 款产品未经授权擅自突出使用"北京同仁堂"字样，涉嫌违法，公司已启动司法程序，对涉事企业进行起 诉。 近期，宣称能"改善大脑功能、守护心血管、增强免疫力"的南极磷虾油，在网络热销。 12月11日，上海市消保委发布了15款不同品牌的南极磷虾油产品比较检测结果。其中，一款名为"北京 同仁堂99%高纯南极磷虾油"的产品，其磷脂标识值为43%，但实测却为0。 上海市消保委表示，针对相关企业涉嫌造假行为，为了保护消费者合法权益，将于近日约谈北京同仁堂 （四川）健康药业有限公司等相关企业，要求其对产品的真实情况做出解释。 MegaRed 京东京造 NY03 北京同仁堂 Swisse goodhealth vik Cuixo 日本山 汤臣倍健 彩 d Super Kr GNITE 封面图片来源：图片来源：每日经济新闻 资料图 15款 ...

转自：北京日报客户端 据天眼查信息显示，12月11日，深圳罗马仕科技有限公司因违反强制认证规定、虚假宣传，被深圳市市 场监督管理局南山监管局没收违法所得1.2万余元、罚款123万元。 | 行政处罚决定书文号: | 深市监南处罚〔2025〕 稽57号 | | --- | --- | | 处罚名称: | 深圳罗马仕科技有限公司违反强制认证规定、虚假宣传案 | | 处罚类别: | 没收违法所得;罚款 | | 处罚事由: | 认证认可违法行为 | | 处罚依据: | 中华人民共和国反不正当览争法/期四章法律责任/第二十五条/第一款经营者违反本法第九条规定对其商品作虚假或者引人误, 解的商业宣传,或者通过组织虚假交易、虚假评价等方式帮助其他经营者进行虚假或者引人误解的商业宣传的,由监督检查 部门费令停止违法行为;处一百万元以下的罚款;情节严重的,处一百万元以上二百万元以上二百万元以下的罚款,可以并处吊销营业执 照。中华人民共和国反不正当竞争法(2019修正)3ğ图章法律责任/第二十条/澳1款经营者违反本法题八条规定对其随品作虚- 假成者引人误解的商业宣传,或者通过组织虚假交易等方式帮助其他经营者进行虚假或者引人误解的商 ...

Core Viewpoint - The article discusses the controversy surrounding Xiaomi's advertising practices, particularly the use of small print disclaimers that mislead consumers, and highlights a recent shift in Xiaomi's approach to advertising transparency [5][14][30]. Group 1: Xiaomi's Advertising Practices - Xiaomi has been criticized for its use of "small print" disclaimers in advertisements, which can mislead consumers about product features and performance [5][16][30]. - The article references a specific instance where Xiaomi's promotional claims were scrutinized, leading to public backlash and comparisons to industry-wide practices [5][14]. - In response to criticism, Xiaomi has made changes to its advertising, such as removing small print disclaimers and providing clearer information about product features [8][21]. Group 2: Industry Implications - The article emphasizes that the issue of misleading advertising is not unique to Xiaomi but is a widespread problem across the consumer market, affecting various sectors including electronics and automotive [13][14]. - It argues that the prevalence of "small print" tactics undermines consumer trust and calls for a shift towards more transparent advertising practices across the industry [16][32]. - The article suggests that Xiaomi's decision to change its advertising approach could set a precedent for other companies, potentially leading to a broader industry reform [21][32]. Group 3: Consumer Impact - Consumers are often unaware of the implications of small print disclaimers, which can lead to misunderstandings about product capabilities and safety [15][18]. - The article warns that misleading advertising can result in significant consumer dissatisfaction and safety risks, particularly in high-tech sectors like electric vehicles [17][18]. - It advocates for a more honest advertising environment where consumers do not have to scrutinize every detail to understand product offerings [32]. Group 4: Public Relations and Corporate Responsibility - The article criticizes Xiaomi's lack of communication following the controversy, suggesting that proactive engagement could enhance its reputation and influence in the industry [24][25]. - It highlights the importance of corporate responsibility in advertising, noting that companies should prioritize consumer trust over short-term marketing gains [20][28]. - The article concludes that a commitment to transparency and honesty in advertising will ultimately benefit both consumers and companies in the long run [33].

Core Viewpoint - The article highlights the ongoing issue of false advertising in the healthcare sector, particularly regarding glucosamine products and lutein, which claim to provide unverified health benefits [4][5][6]. Group 1: False Advertising Practices - Some companies continue to promote glucosamine products with misleading claims about joint health and cartilage repair, despite previous exposure and regulatory actions [4][5]. - Lutein brands are using indirect methods to suggest their products can prevent myopia, without making direct claims [5]. Group 2: Regulatory Challenges - The imbalance between the low cost of violations and the high profit margins from misleading advertising allows companies to continue these practices with minimal consequences [6]. - Current regulatory measures are reactive rather than proactive, lacking real-time monitoring of marketing content across different platforms [6]. Group 3: Consumer Vulnerability - Consumers often lack the necessary knowledge to discern the actual efficacy of glucosamine and lutein, making them susceptible to misleading claims [6]. - Misleading marketing tactics, such as false endorsements from "overseas brands" or "doctor recommendations," exploit consumer ignorance [6]. Group 4: Recommendations for Improvement - A systematic and long-term regulatory mechanism is needed, including enhanced pre-approval responsibilities for e-commerce platforms to monitor health product advertising [7]. - Increasing penalties for companies that continue to engage in misleading marketing practices is essential to deter such behavior [7]. - Public education on the actual benefits and limitations of glucosamine and lutein should be strengthened to reduce the space for false advertising [7].

Core Viewpoint - The article criticizes the marketing tactics of certain companies, particularly focusing on the misleading use of large and small text in advertisements, which can mislead consumers and undermine trust in the brand [2][4][24]. Group 1: Marketing Tactics - Companies are increasingly using the tactic of "big text for attention, small text for disclaimers," which has become prevalent in various industries, including automotive and technology [6][9]. - The media has summarized this tactic as "three blows": exaggerating effects, inflating sales, and overstating discounts [6]. - An example highlighted is a smartphone advertisement that prominently claims to be the "King of Backlight," while a small disclaimer states that this is merely a design goal, raising questions about the legitimacy of such claims [6][9]. Group 2: Specific Company Examples - Xiaomi's marketing strategies have come under scrutiny, particularly regarding the promotion of its 17 Pro series smartphone, which has been accused of misleading advertising practices [9][11]. - The controversy extends to other Xiaomi products, such as the SU7 Ultra, which claimed to be the "fastest four-door production car," but included a small disclaimer stating it was a goal rather than a fact [12][20]. - Consumers have expressed frustration over Xiaomi's marketing, feeling deceived by the use of aspirational language that does not reflect actual product capabilities [20][24]. Group 3: Industry Implications - The article suggests that such marketing practices, while potentially profitable in the short term, could ultimately damage consumer trust and the overall market environment [24][33]. - There is a call for the industry to establish clearer marketing standards, emphasizing that creativity in marketing should not come at the expense of honesty [24][33]. - Xiaomi has begun to adjust its marketing approach in response to public criticism, moving towards more transparent and straightforward advertising [25][27].

央广网北京12月8日消息（总台中国之声记者任梦岩）据中央广播电视总台中国之声《新闻纵横》 报道，睡觉打呼噜是困扰不少人的生活难题，不知道您试过多少办法解决问题？在电商平台上搜索"止 鼾"，会看到各式各样的"止鼾神器"——有的像鼻环一样，号称夹在鼻子里就能快速止鼾；有的像在鼻 子上插个"小电风扇"往里送气；还有的号称贴一副膏药就能达到止鼾效果；甚至有号称通过"电磁脉 冲"刺激肌肉止鼾的产品…… 国家食品药品监督管理总局发布的《医疗器械分类目录》明确，以达到改善打鼾状况或扩张鼻孔的 止鼾器、通气鼻贴等产品被明确划分为第二类医疗器械。第二类医疗器械指的是具有中度风险，需要严 格控制管理以保证其安全、有效的医疗器械。 《中华人民共和国广告法》第十七条也明确规定，除医疗、药品、医疗器械广告外，禁止其他任何 广告涉及疾病治疗功能，并不得使用医疗用语或者易使推销的商品与药品、医疗器械相混淆的用语。 这些产品的价格从两元到200多元不等，共同的特性是都不属于医疗器械，按照相关法规要求，不 能宣传其具有止鼾功能，但在各大电商平台上，这些产品不仅被宣传为"止鼾神器"，有的干脆是"三 无"商品。此类商品为何能"畅行"电商平台？ 浙 ...

Core Viewpoint - The recent controversies surrounding Xiaomi's SU7 model have led to significant public criticism and a potential crisis for the company, as trust in both Xiaomi and its founder Lei Jun appears to be eroding rapidly [1][6][30]. Group 1: Product Launch and Initial Success - Xiaomi's SU7 model was launched with high expectations, achieving monthly sales of over 40,000 units within a short period, indicating strong market acceptance [8]. - The initial success of Xiaomi's automotive venture was largely attributed to Lei Jun's personal influence and the brand's established reputation from previous successful products [10][12]. Group 2: Controversies and Public Backlash - Following the launch, the SU7 faced multiple controversies, including allegations of misleading advertising and quality control issues, which have sparked public outrage [6][19]. - A tragic incident involving a user of the SU7 raised serious concerns about the vehicle's safety features, further damaging the brand's reputation [6][22]. Group 3: Implications of Apology - Lei Jun's potential apology could signify an admission of failure, risking both personal and brand credibility, and could lead to significant financial liabilities for Xiaomi [12][23]. - The legal ramifications of admitting to misleading advertising could result in substantial compensation claims from consumers, potentially destabilizing the company's financial standing [18][21]. Group 4: Market Reaction and Stock Performance - Xiaomi's stock has seen a dramatic decline, dropping over 30% from its peak, reflecting negative sentiment from institutional investors amid the ongoing controversies [24][26]. - The company's stock performance is closely tied to the success of its automotive division, making any admission of fault particularly damaging to its market value [23][27]. Group 5: Leadership and Future Outlook - Lei Jun's leadership is under scrutiny as the company navigates these challenges, with the need to maintain consumer trust and investor confidence becoming increasingly critical [30][31]. - The current situation highlights the delicate balance between addressing public concerns and protecting the company's long-term interests, as any misstep could lead to broader repercussions across Xiaomi's diverse business segments [31][32].